BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 1723407)

  • 1. Chemotherapy for advanced testicular cancer.
    Fox EP; Loehrer PJ
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1173-87. PubMed ID: 1723407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of the testis: a new paradigm.
    Einhorn LH
    Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy for germ cell tumors.
    Motzer RJ; Bosl GJ
    Urol Clin North Am; 1987 May; 14(2):389-98. PubMed ID: 2437682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
    Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
    Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in clinical therapeutics: testicular cancer.
    Bergmann KA
    Clin Pharm; 1987 Sep; 6(9):693-706. PubMed ID: 2445518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of good risk germ-cell tumours.
    Troost MM; Sternberg CN; de Wit R
    BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
    Bokemeyer C
    J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
    Raghavan D; Levi J; Thomson D; Harvey V
    Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of bilateral germ cell tumor of the testis].
    Saito M; Kondo A; Kinjo T
    Hinyokika Kiyo; 1989 Nov; 35(11):1961-4. PubMed ID: 2482675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
    Sparwasser C; Treiber U; Beckert R; Pust RA
    Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of advanced testicular cancer].
    Murase T; Takashi M; Sobashima T; Shimoji T; Miyake K; Mitsuya H
    Hinyokika Kiyo; 1987 Jan; 33(1):47-50. PubMed ID: 2437779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
    Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
    de Haas EC; Zwart N; Meijer C; Nuver J; Boezen HM; Suurmeijer AJ; Hoekstra HJ; van der Steege G; Sleijfer DT; Gietema JA
    J Clin Oncol; 2008 Apr; 26(11):1817-23. PubMed ID: 18398146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
    Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
    Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy for metastatic germ cell tumours of the testis].
    Culine S
    Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.